Maj. Jason Watson, who was in uniform, was arrested during a protest that followed a news conference on Wednesday. By Aimee Ortiz See more of our coverage in your search results.Encuentra más de ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. David Meek bought Bluebird Bio last year ...

A new gene-editing company called Serapha Bio emerged from stealth on June 23, 2026 with $230 million in committed financing and a one-time therapy designed to correct the genetic root cause of ...

A new gene-editing company emerged from stealth on Tuesday with $230 million in committed financing, a reverse merger with a defunct oncology biotech, and a lead drug candidate licensed from a Chinese ...

The “Harry Potter” star was seen at an event also attended by Prince William and Benedict Cumberbatch. She was last on the big screen in 2019’s “Little Women.” Joey Nolfi is a senior writer at ...

When writing a blockbuster movie script, screenplay writers are sure to include all the essential elements of a hit film. In the biotech world, the launch of Serapha Bio seems to follow this formula, ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

The Green Bay Packers have reportedly made a big-time commitment to one of their most potent big-play threats. They've signed wide receiver Christian Watson to a four-year, $110.5 million extension ...

The Green Bay Packers are locking in an important piece of their core. The Packers signed wide receiver Christian Watson to a four-year, $110.5 million contract extension that includes a $31 million ...

GREEN BAY, Wis. – Is Christian Watson’s injury history ancient history? The Green Bay Packers are betting about $110 million that that’s the case. The Packers and Watson, their premier receiver, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is exploring all ...

Collaboration leverages AAV manufacturing expertise to advance a preclinical-stage gene therapy program for a rare pediatric neurological disorder. SAN SEBASTIÁN, Spain and LONDON, May 5, 2026 ...